|
Re: BiOasis BioTuesday article
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 14, 2016 11:54PM
|
|
Re: AGM DATE NOT RELEASED
|
2
|
Zenith Epigenetics
|
Sep 27, 2017 10:20AM
|
|
Re: I think one major reason that,
|
2
|
Resverlogix Corp.
|
Nov 01, 2019 05:30PM
|
|
Zenith Corporate Update
|
2
|
Zenith Epigenetics
|
Dec 02, 2016 02:23PM
|
|
Re: BET inhibition in renal and cardiovascular disease: What is the clinical roadmap? VIDEO
|
2
|
Resverlogix Corp.
|
Jun 23, 2017 10:57AM
|
|
Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
2
|
Zenith Epigenetics
|
Jun 14, 2016 07:25AM
|
|
Re: Congratulations to old timers and a question on composition of the trial
|
2
|
Resverlogix Corp.
|
Apr 23, 2019 08:59AM
|
|
Re: Biotech Showcase January 8-10, 2018
|
2
|
Resverlogix Corp.
|
Dec 28, 2017 02:20PM
|
|
Re: The waiting game.....
|
2
|
Resverlogix Corp.
|
Feb 13, 2019 09:20AM
|
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Feb 21, 2020 03:19PM
|
|
Re: Resverlogix BIO CEO & Investor Conference 2017 Slides
|
2
|
Resverlogix Corp.
|
Feb 15, 2017 11:46AM
|
|
Re: P3
|
2
|
Resverlogix Corp.
|
Jun 19, 2015 10:34AM
|
|
Re: BioPub Bioasis Webcast
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 01, 2019 06:34PM
|
|
Re: If BETONMACE were to be done again today,...
|
2
|
Resverlogix Corp.
|
Nov 19, 2019 09:01AM
|
|
Resverlogix Commences Dosing in Phase 3 Clinical Trial BETonMACE
|
2
|
Resverlogix Corp.
|
Nov 11, 2015 11:47AM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 11:00AM
|
|
Re: The final events.....
|
2
|
Resverlogix Corp.
|
Jan 25, 2019 11:11AM
|
|
Re: I can buy Apabetalone today?
|
2
|
Resverlogix Corp.
|
Sep 20, 2016 08:32PM
|
|
Re: New posting on my blog...
|
2
|
Resverlogix Corp.
|
Nov 11, 2016 11:36AM
|
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Feb 28, 2018 03:21PM
|
